Top compounds associated with response to BHMT


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.7
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.0097 0.7
mRNA Erlotinib gCSI pan-cancer AAC -0.019 0.7
mRNA CEP-701 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.012 0.7
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.0094 0.8
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.0098 0.8
Download CSV